Skip to content

Puma Biotechnology, Inc.

PBYI· NasdaqCore metricsCIK 1401667

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -0.06%
Market cap
$417.98M
51.7M shares
Filings
1,023
$55.06M
Q3 2026−0.9% FY25 yoy
$5.96M
Q3 2026+2.8% FY25 yoy
$5.27M
Q3 2026+20.5% FY25 yoy
$31.62M
Q3 2026derived+7.4% FY25 yoy
$0.11
Q3 2026−1.6% FY25 yoy
$41.55M
Q3 2026−57.2% FY25 yoy
$417.98M
17.5×
1.8×
2.9×
11.02%
—

Twelve months to Sep 30, 2026 · derived

Price

$8.09+55.48%+$2.89past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$228.37MFY 2025
$272.26M0FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$228,371,000reported
FY 20242024-12-31$230,468,000reported
FY 20232023-12-31$235,637,000reported
FY 20222022-12-31$228,031,000reported
FY 20212021-12-31$253,155,000reported
FY 20202020-12-31$225,110,000reported
FY 20192019-12-31$272,260,000reported
FY 20182018-12-31$250,991,000reported
FY 20172017-12-31$27,685,000reported

Segments

Products
Revenue by Products, FY2018 to FY2025FY2018Product · FY2018 · $200.49MLicense · FY2018 · $50.50MFY2019Product · FY2019 · $211.62MRoyalty · FY2019 · $391.00KLicense · FY2019 · $60.25MFY2020Product · FY2020 · $196.73MRoyalty · FY2020 · $5.68MLicense · FY2020 · $22.70MFY2021Product · FY2021 · $189.06MRoyalty · FY2021 · $12.34MLicense · FY2021 · $51.75MFY2022Product · FY2022 · $200.02MRoyalty · FY2022 · $28.01MFY2023Product · FY2023 · $203.11MRoyalty · FY2023 · $32.53MFY2024Product · FY2024 · $195.19MRoyalty · FY2024 · $35.28MFY2025Product · FY2025 · $204.07MRoyalty · FY2025 · $24.30M
LineFY2025ShareChange
Product$204.07M89%+4.6%
Royalty$24.30M11%−31.1%
License———
Total$228.37M

From the 10-K filed Feb 26, 2026PBYI

Pharmaceutical preparations

Puma Biotechnology, Inc. is the 81st largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Puma Biotechnology, Inc. · CIK 1401667 · Engraved from SEC EDGAR